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BLOOD PRESSURE PREDICTION MODEL FOR HYPERTENSIVE 
PATIENTS AT SARABURI HOSPITAL IN 2009
Auamnoy T, Siemmai A, Tantipidoke R
Chulalongkorn University, Bangkok, Thailand
OBJECTIVES: 1. To compare means of calories burnt by exercise (exercise), compli-
ance, eating behavior, hypertension knowledge, age and blood pressure (BP) between 
gender and 2. To ﬁ nd correlations between exercise, compliance, eating behavior 
score, hypertension knowledge, age and blood pressure. 3. To employ Hierarchical 
Stepwise Multiple Regression Analysis (MRA) to predict blood pressure. METHODS: 
A retrospective research by face to face interview and clinical outcomes were used to 
investigate relationships between 6 variables and BP of random 200 hypertensive 
patients at Saraburi Hospital 2009. RESULTS: Total (N) 200 (100%) patients were 
mostly female 118 (59.00%) and 82 (41.00%) were male. The average age was 52.21 
± 12.01 years, average exercise per week 2787.24 ± 141.61 kcal, average compliance 
score 7.41 ± 1.93, average SBP and DBP were 150.24 ± 18.49 and 89.40 ± 9.15 Hgmm. 
Cronbach’s Alpha coefﬁ cient of Sorofman’s Compliance scale for constructs “right 
time” and “right amount” were 0.7978, and 0.7896 respectively, Auamnoy Eating 
Behavior Scale was 0.7915. ANOVA conﬁ rmed that BP, compliance, hypertension 
knowledge, age, exercise and eating behavior score between male and female were not 
signiﬁ cantly different (p > 0.05). Pearson’s correlation conﬁ rmed that age, exercise 
and compliance had signiﬁ cant negative correlation with DBP (r = −0.19, −0.43, −0.60 
with p = 0.00, 0.00, 0.00 respectively). Age had signiﬁ cant positive correlation with 
SBP however exercise and medical regimens compliance had signiﬁ cant negative cor-
relation with SBP (r = 0.16, −0.81, −0.98 with p = 0.02, 0.00, 0.00 respectively). MRA 
equation demonstrated the three most signiﬁ cant variables those predicted SBP and 
DBP were: compliance (Beta = −0.90, −0.70), eating behavior (Beta = 0.82, 0.72) and 
exercise (Beta = −0.11, −0.29) P = 0.00, 0.00, 0.00 R2 = 0.58, 0.55 respectively. 
CONCLUSIONS: The more patients complied to medical regimens, with good eating 
behavior and the more exercise the less patients’ blood pressure was.
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THE MISSING PIECE BETWEEN TREATMENT EXPERIENCE AND 
INTENTION TO PERSIST: TESTING THE INTERNAL CONSISTENCY 
RELIABILITY AND PREDICTIVE VALIDITY OF ACCEPTABILITY
Chretin S1, Viala-Danten M2, Van Ganse E3, Patrick D4, Arnould B2, Longin J1
1Registrat–Mapi, Lyon, France; 2Mapi Values, Lyon, France; 3Hôpital Neurologique Pierre 
Wertheimer, BRON Cedex, France; 4University of Washington, Seattle, WA, USA
OBJECTIVES: The ACCEPT© questionnaire is a self-administered generic accept-
ability instrument assessing how patients balance the advantages and disadvantages 
of long-term chronic therapy. It is made of 2 parts: 1/ several characteristics of patient 
experience with treatment giving an indication on which treatment attributes are 
leading to intentions and adherence; 2/ a scale measuring acceptability of the treat-
ment. Our objective was to test the internal consistency reliability and predictive 
validity of the acceptability scale. METHODS: A survey was conducted in 60 com-
munity pharmacies. Patients treated with statin for more than 3 months were asked 
to complete a preliminary version of the acceptability scale (3 items), as well as ques-
tions regarding their compliance with their statin medication. Compliant patients were 
deﬁ ned as those who reported never to forget to take their statin medication. Internal 
consistency of the acceptability scale was assessed by Cronbach’s alpha. The statistical 
independence between the 3 acceptability items and compliance was investigated by 
chi-2 tests. The ability of the 3 acceptability items to detect non compliant patients 
was evaluated by the area under the Receiver Operating Characteristic (ROC) curve. 
RESULTS: Out of 443 patients included in the analysis, 28% have been treated for 
1 to 3 years, and 54% for more than 3 years. 60% had no cardiovascular antecedent, 
14% had an angina, 13% a prior myocardial infarction, 6% a prior stroke. 66% 
declared they never forgot to take their statin medication. Cronbach’s alpha of the 
acceptability scale was 0.70. The 3 items were statistically related to compliance 
(p-chi2 < 0.0001). The area under the ROC curve was 0.69. CONCLUSIONS: The 
acceptability scale showed satisfying preliminary results of reliability and predictive 
validity. Further work is needed to validate the scale in other long-term treated popula-
tions and to evaluate its ability to predict persistence to treatment over time.
PCV107
VALUATION OF HEALTH STATE UTILITIES RELATED TO 
CARDIOVASCULAR PREVENTION WITH ASPIRIN
Manson SC1, van Hanswijck de Jonge P1, Palsgrove A2, Gorelick PB3
1United BioSource Corporation, London, UK; 2United BioSource Corporation, Bethesda, 
MD, USA; 3University of Illinois College of Medicine, Chicago, IL, USA
OBJECTIVES: The primary aim of the study was to determine societal utility scores 
for health states associated with events either beneﬁ ting from aspirin (myocardial 
infarction, stroke, angina) or potentially caused by aspirin (GI bleeding). The second-
ary aim was to determine the societal disutility score of taking aspirin every day. 
METHODS: Draft health states were developed based on a brief literature review and 
exploratory and validation interviews with cardiovascular (n = 3) and stroke (n = 2) 
specialists. The ﬁ nal health states were tested in a pilot study with members of the 
general public (n = 6). In the main study, members of the general public (n = 90 
Canadians; n = 86 Americans) completed a chained standard gamble (SG) interview, 
a Visual Analogue Scale (VAS) rating task (0–100), the EQ-5D and a socio-demo-
graphic form. RESULTS: The samples were a reasonable match to the population of 
Canada and the US in terms of demographics (48% female, 67% white) and quality 
of life (rated by EQ-5D). Eight percent of participants had experienced one or more 
forms of CVD or stroke as described in the health states and 18% of participants were 
taking daily preventive aspirin. In patients who were not taking aspirin, adding daily 
aspirin to prevent CVD caused a decrement in utility of 0.018. Conversely, patients 
who were taking daily aspirin reported an increase in utility of 0.021 compared to if 
they were not taking aspirin. GI bleeding and transient ischemic attack were rated as 
the states with the highest utility (0.79) followed by angina (0.71 stable, 0.66 unsta-
ble). Various stages of MI and stroke were considered least desirable (0.10–0.63). 
CONCLUSIONS: The study highlights the beneﬁ t in utility that could be gained from 
preventing cardiovascular and stroke events. It also demonstrates that the minor 
burden of taking aspirin daily changes to a small incremental beneﬁ t in wellbeing in 
participants already taking aspirin.
PCV108
METHODS FOR ESTIMATING HEALTH-STATE UTILITIES IN 
PULMONARY ARTERIAL HYPERTENSION
Mychaskiw MA1, Berger A2, Mardekian J1, Hwang LJ1, Oster G2
1Pﬁ zer Inc, New York, NY, USA; 2Policy Analysis Inc., Brookline, MA, USA
OBJECTIVES: To compare health-state utility values obtained using three different 
instruments administered to patients with pulmonary arterial hypertension (PAH) 
enrolled in a randomized controlled trial of sildenaﬁ l. METHODS: Data for this study 
were obtained from a large phase III clinical trial in which patients were randomized 
to receive either sildenaﬁ l or placebo for 12 weeks. At each visit (baseline, weeks 1, 
4, 8, and 12 of follow-up), patients were administered the Short Form-36 General 
Health Survey (SF-36) and the EuroQol Health Survey (EQ-5D); additionally they also 
were asked to provide a direct assessment of their current health state using a visual 
analog scale (VAS). Responses to the SF-36 and EQ-5D were then converted to health-
state utility values using published algorithms. Patients were pooled across treatment 
groups, and attention was focused on baseline values. Statistical signiﬁ cance of differ-
ences between these three estimates was ascertained using paired t tests. RESULTS: 
There were a total of 274 patients across both treatment groups in the intent-to-treat 
population. Proportions of 0–30, 31–60, and 61–100 health-state utility values were 
0.4%, 22.6%, and 77.0% for SF-36; 16.2%, 9.6%, and 74.3% for EQ-5D; and 8.6%, 
47.2%, and 44.2% for VAS, respectively. Mean (95% conﬁ dence intervals) health-
state utility values were 71.4 (69.6–73.1) for SF-36 (P < 0.01 vs. EQ-5D or VAS), 
63.2 (60.2–66.3) for EQ-5D (P < 0.01 vs. VAS), and 59.0 (56.9–61.2) for VAS, 
respectively. CONCLUSIONS: Ratings of current health by PAH patients are signiﬁ -
cantly worse with a single-item VAS scale than based on responses to the EQ-5D and 
SF-36 health questionnaires. The EQ-5D appears to yield somewhat lower values than 
the SF-36. Further research is needed to better understand the reason(s) for these 
differences.
PCV109
SEVENTY-SEVEN HEALTH STATE UTILITIES ESTIMATED IN POLISH 
CARDIAC PATIENTS
Zawodnik S, Golicki D, Hermanowski T
Department of Pharmacoeconomics, Medical University of Warsaw, Warsaw, Poland
OBJECTIVES: The aim of this study was to create a catalogue of SF-6D health state 
utility values in the cardiovascular diseases, based on studies conducted in Polish 
population using the SF-36 questionnaire. METHODS: Five databases: MEDLINE, 
EMBASE, Cochrane Database, SCOPUS, Polish Medical Bibliography (Polska Biblio-
graﬁ a Lekarska; accessed on April 23, 2010) were systematically searched for SF-36 
quality of life studies conducted in Polish cardiac patients. Only studies using original 
key answer and with published complete data for eight SF-36 dimensions were 
included. SF-6D utility scores were estimated based on SF-36 population data using 
the method published by Ara and Brazier in 2009. RESULTS: We initially identiﬁ ed 
31 studies using SF-36 in Polish cardiac patients. In 14 studies proper SF-36 scoring 
algorithm was used and data for all eight domains were available. Data for 77 different 
health states related to ﬁ ve cardiac disorders were extracted: acute coronary syndrome, 
coronary artery disease, hypertension, atrial ﬁ brillation and aortic valve disease. Each 
health state was described as value of 8 dimensions of quality of life and was converted 
to single-ﬁ gure utility. Utility of acquired 77 health states ranged from 0.41 to 0.78. 
CONCLUSIONS: A catalogue of 77 health state utilities derived in Polish cardiac 
patients was estimated. It can be useful in pharmacoeconomic analyses conducted for 
cardiologic health technologies and should support reimbursement decision making 
in Poland.
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HOW PATIENTS’ EXPERIENCE COULD INFLUENCE THEIR 
PREFERENCES TOWARD TREATMENT FOR ABDOMINAL AORTIC 
ANEURYSM: RESULTS FROM THE PREFER STUDY
Scalone L1, Borghetti F2, Faggioli G3, Stella A3, Cortesi PA1, Mantovani LG4
1University of Milano—Bicocca, Monza, Italy; 2University of Milan, Milano, Italy; 3Sant’Orsola 
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OBJECTIVES: Factors inﬂ uencing preferences towards treatment of abdominal aortic 
aneurysm (AAA) were scarcely investigated. To identify how patients’ experience can 
affect their preferences for treatment of AAA. METHODS: within a multicentre 
Discrete-Choice-Study aimed to assess preferences toward AAA treatment the partici-
pant patients responded to 4 pair-wise choice sets comparing treatment options 
obtained from a factorial combination of 6 characteristics: type of anaesthesia 
(general vs. local); recovery time to everyday basic activities (2 vs. 4 days); risk of 
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re-intervention at 5 years (7% vs. 15%); complexity of follow-up (with vs. without 
CT examination); risk of major complications (2% vs. 5%); additional cost of inter-
vention (c0 vs. c2000). Patients preferences were elicited before treatment (NAIF) and 
after treatment with open surgery (OPEN) or endovascular procedure (EVAR). a 
segmentation conditional logistic regression model was applied to estimate relative 
importance (RI) assigned to each characteristic according to patients’ experience with 
treatment. RESULTS: A total of 160 patients participated (aged 49–88 years, 91.7% 
male) from 9 hospitals. Fifty-two percent were NAIF at enrolment. Overall, half 
patients were treated with OPEN, half with EVAR. One most important characteristic, 
risk of procedural major complications, was considered more important by NAIF and 
EVAR than OPEN (RI = 31.7% and 22.0% vs. 11.0%). Additional costs were more 
important to OPEN (RI = 38.3%) than NAIF (25.2%) and EVAR (19.5%). Local 
anaesthesia was more important to EVAR (24.8%) than NAIF or OPEN (RI = 8.5%). 
Risk of repeating the procedure was similarly important to treated patients (RI = 
17.5%), less to NAIF (RI = 12.3%). Recovery time was more important to OPEN (RI 
= 14.3%) and EVAR (RI = 10.3%) than NAIF (8.6%). Type of follow-up tests was 
least important, with OPEN and NAIF preferring less complex tests (RI = 4–10%), 
but EVAR preferring more complex tests (RI = 6%). CONCLUSIONS: Preferences 
depend on experience, knowledge and expectancies. Understanding patients’ prefer-
ences can help physicians to optimize beneﬁ ts of treatments.
PCV112
QUALITY OF LIFE AND DEPRESSION AMONG ADULTS WITH TYPE 2 
DIABETES MELLITUS, HYPERTENSION, AND OBESITY
Grandy S1, Fox KM2
1AstraZeneca LP, Wilmington, DE, USA; 2Strategic Healthcare Solutions, LLC, Monkton, MD, 
USA
OBJECTIVES: Individuals with type 2 diabetes mellitus (T2DM) are known to have 
poorer quality of life and more depressive symptoms than those without diabetes, yet 
the impact may be in part due to comorbid conditions. This study compared quality of 
life and depression among adults with T2DM and comorbid hypertension (HTN) and 
obesity with adults reporting T2DM only. METHODS: Respondents to the Study to 
Help Improve Early evaluation and management of risk factors Leading to Diabetes 
(SHIELD), a large US survey, self-reported their height, weight, and comorbid condi-
tions, and completed the Short Form- 12 (SF-12) and Patient Health Questionnaire 
(PHQ-9, depression assessment). Respondents reporting T2DM and HTN and obesity 
(body mass index [BMI] ≥30 kg/m2) were identiﬁ ed and compared with a T2DM-only 
group. RESULTS: Respondents with T2DM and comorbid HTN and obesity (n = 1292) 
were similar to T2DM-only respondents (n = 349) in race, education, smoking, and 
cardiovascular disease history (all p > 0.05), but were younger and were more likely to 
be men and have lower income (P < 0.01). Respondents with T2DM, HTN and obesity 
had signiﬁ cantly lower Physical and Mental Component Summary scores (37.3 and 
50.9, respectively) than T2DM-only respondents (45.8 and 53.5, respectively, P < 
0.0001). Mean PHQ-9 scores were signiﬁ cantly higher among T2DM respondents with 
comorbid HTN and obesity (5.0 vs. 2.5, P < 0.0001), indicating greater depression 
burden. Approximately 16.5% of respondents with T2DM, HTN and obesity had 
moderate to severe depression (PHQ-9 scores ≥15), compared with 6.1% of respondents 
with T2DM only (P < 0.0001). CONCLUSIONS: SHIELD respondents with T2DM, 
HTN and obesity report a lower quality of both physical and mental health and more 
depression symptoms than the T2DM-only group. More research is needed to determine 
whether the poor quality of life and greater depression in this population affects self-
management of their diabetes and comorbid conditions.
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HEALTH-RELATED QUALITY OF LIFE OF PATIENTS UNDERGOING 
PERCUTANEOUS CORONARY INTERVENTION COMPARED TO 
HEALTHY SUBJECTS IN HONG KONG
Lee VW, Yan B, Choy A, Yeung S, Yu CM
The Chinese University of Hong Kong, Shatin, Hong Kong
OBJECTIVES: This study aimed to investigate the health-related quality of life 
(HRQoL) of coronary heart disease (CHD) patients and healthy subjects in Hong 
Kong. METHODS: This study was a one-year prospective cohort with two groups of 
study populations, the patient group and healthy subject group. Thirty-three eligible 
patients were recruited from Prince of Wales of Hospital. The HRQoL data using 
Short-Form 36-item Health Survey (SF-36) were collected just after percutaneous 
coronary intervention (PCI) (baseline) and one year post-PCI. Thirty-ﬁ ve healthy 
subjects who were recruited from two elderly centres and parents of School of Phar-
macy (SOP) students, were also interviewed by SF-36. This study consists of two parts. 
In the ﬁ rst part, the HRQoL data of healthy subjects were compared with patients at 
baseline and 1 year post-PCI respectively. In the second part, the improvement in 
HRQoL of PCI patients at baseline and 1 year post-PCI was compared. RESULTS: 
In the ﬁ rst part of study, healthy subjects had signiﬁ cantly (P < 0.05) higher scores in 
role-physical (79.3 ± 36.6 vs. 53.8 ± 48.1), vitality (65.1 ± 23.8 vs. 49.5 ± 33.7) and 
role-emotional (93.3 ± 15.8 vs. 72.7 ± 39.5) than the patients at baseline. Patients’ 
HRQoL returned to similar level with healthy subjects after 1 year of PCI treatment. 
In the second part of the study, patients had signiﬁ cant (P < 0.05) improvements in 
bodily pain (12.7 ± 30.3) and vitality (16.1 ± 33.1) after 1 year. CONCLUSIONS: 
This study showed that the HRQoL of CHD patients was poorer than healthy popula-
tion in Hong Kong, but returned to similar level as healthy population after 1 year of 
PCI treatment. In addition, signiﬁ cant HRQoL improvements had been seen in patients 
after 1 year of PCI, especially in bodily pain and vitality.
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ABSENTEISM AND IMPAIRED QUALITY OF LIFE IN CHRONIC VENOUS 
DISEASE IN ROMANIA
Alegre P1, Puskas A2, Giurcaneanu C3, Andercou A4, Jantet G5
1Science Union et cie (Servier), Suresnes, France; 2Targu Mures, Romania; 3Bucarest, 
Romania; 4Cluj, Romania; 5Paris, France
OBJECTIVES: To evaluate the impact of chronic venous disease (CVD) on patients’ 
professional activity and its consequence on patients’ quality of life (QOL) in 
Romania. METHODS: A large observational, multicentre, descriptive survey in CVD 
was implemented in Romania in 2009. Impact of CVD on patients’ professional 
activities and QOL were documented based on a patient self-administered question-
naire. The CIVIQ-14 was used to assess QOL (score 0 for very good to 100 for bad 
QOL). Patient data were crossed with their general practitioner evaluations on the 
severity of the disease. RESULTS: Out of 2542 screened patients, 2294 ﬁ lled in the 
questionnaire (90.2%). Among CVD patients, 7% had had hospitalization because of 
the disease, while 7% had changed their professional activities or had lost working 
days. Number of lost working days over the previous 5 years exceeded 1 week for 
most (40% lost >1 week, 35% >1 month, 16% <1 week). Patients who lost less than 
1 working week, between 1 week and 1 month and more than 1 month due to CVD 
had a worsened QOL (respectively 28.71 ± 24.32, 31.4 ± 17.73 and 31.8 ± 16.69 
CIVIQ-14 score) QOL scores paralleled the severity of CVD, going from 15.64 ± 
14.94 in C0s patients (symptoms only, according to the CEAP) to 51.79 ± 30.43 in 
C6 (patients with ulcer). The presence of pain decreased QOL (30.49 ± 19.04). QOL 
scores associated to work absenteeism varied from 21.98 ± 15.05 to 49.49 ± 20.06 
depending on absenteeism frequency (from 1 to 3 times respectively) CONCLUSIONS: 
CVD generates an important negative professional impact in Romania with productiv-
ity losses. Quality of life impairment occurs from the ﬁ rst symptoms of CVD and it 
is correlated to the work absenteeism duration and frequency. Three times out of work 
is associated to a QOL score comparable to the one quoted between grades 4 and 5 
of the CEAP classiﬁ cation.
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ASSESSMENT OF THE ASSOCIATION BETWEEN SUMMARY SYMPTOM 
MEASURES AND HEALTH STATUS OF PATIENTS WITH ISCHEMIC 
HEART DISEASE
Kaakeh R, Erickson SR
University of Michigan, Ann Arbor, MI, USA
OBJECTIVES: This study compared ﬁ ve methods of summarizing symptom data and 
the association of these measures with the outcome health related quality of life 
(HRQL) in patients who had experienced an acute coronary syndrome event (ACS). 
METHODS: All patients listed in an ACS registry (treated for ACS and discharged 
from a university afﬁ liated hospital) during a 3 year period were mailed a question-
naire that assessed symptom status, demographics, cardiac functional status and 
therapy, comorbidity, ACS type and HRQL (SF-8 and EQ-5D). The symptom survey 
included 24 symptoms and measured the occurrence, frequency, and distress associ-
ated with each symptom during the previous four weeks. Symptom summary measures 
included summed, averaged, and multiplicative (Symptom Product) values of each 
symptom characteristic. Bivariate correlations and multivariate regression analysis 
were used to assess the association of each symptom summary measure with HRQL, 
controlling for other patient, disease, and treatment characteristics. RESULTS: A total 
of 490 of 1217 patients (40%) responded. The mean age was 65.7 ± 11.3 years; 67.7% 
male;94.0% Caucasian;PCS-8 53.7 ± 10.5; MCS-8 49.5 ± 9.5; and EQ-5D VAS 73.6 
± 20.5. The Symptom Sum = 7.8 ± 4.9, Symptom Frequency Average = 2.5 ± 0.72, 
Symptom Distress Average = 2.2 ± 0.8, Symptom Distress Sum = 18.6 ± 14.8, and 
Symptom Product = 51.7 ± 48.3. Bivariate correlations demonstrated that the 
Symptom Sum and Symptom Product had the highest correlation (>0.54) with the 
HRQL domains, while Symptom Frequency Average was the lowest (0.24–0.33). 
The same pattern was seen with the multivariate regression model. The model adjusted 
R-square for the Symptom Sum and Symptom Product measures were higher than the 
other measures, with the Symptom Product having the highest correlation. The 
R-square values ranged for these two measures depending on the HRQL domain; PCS 
(0.38–0.44), MCS (0.33–0.35), EQ-5D (0.34–0.39). CONCLUSIONS: Researchers 
may consider using Symptom Sum or a Symptom Product measures when attempting 
to summarize the association of symptoms with HRQL in ischemic heart disease 
patients.
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QUALITY OF LIFE IN CHRONIC SYMPTOMATIC HEART FAILURE 
PATIENTS IN SPAIN
Marti B1, Delgado J2, Oliva J3, Llano M4, Pascual P5, Comin J6, Grillo JJ7, Diaz Molina B8, 
Culebras J9, Martínez de la Concha L10, Manito N11
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Barcelona, Spain; 7Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de 
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OBJECTIVES: To analyze, for the ﬁ rst time in a large Spanish population of heart 
failure patients, quality of life according to NYHA class II, III or IV using generic 
and speciﬁ c quality of life questionnaires. METHODS: A descriptive analysis of a 
